NUONG NGUYEN: Open Payments
NPI 1629766720 · IOWA CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 51 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $1,254
Food & beverage: $1,153Education: $101
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $266 |
| Teva Pharmaceuticals USA, Inc. | 8 | $185 |
| ABBVIE INC. | 22 | $171 |
| Neurocrine BioSciences, Inc. | 3 | $159 |
| Janssen Pharmaceuticals, Inc | 2 | $139 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $34 |
Products named: LYBALVI, VRAYLAR, INGREZZA, SPRAVATO, Auvelity, CAPLYTA, AUSTEDO XR, COBENFY.
Industry payments across IA — which companies pay providers there.
